# DESCRIPTION

## FIELD OF THE INVENTION

## BACKGROUND OF THE INVENTION

## SUMMARY OF THE INVENTION

## BRIEF DESCRIPTION OF THE SEQUENCES

## DETAILED DESCRIPTION OF THE INVENTION

### General Methods

### Definitions

### Overview

### Inflammatory or Autoimmune Diseases

### Samples

### Detection Methods

### Thresholds

### CD6-ALCAM Pathway Inhibitors

## EXAMPLES

### ELISA-Based Detection of Soluble CD6 and Soluble ALCAM Protein in Urine of Subjects with Lupus Nephritis

### CD6 and ALCAM Expression are Significantly Elevated in Human Renal Tissue Biopsies and are Detectable in Urine Cells from Lupus Nephritis (LN) Patients

### High Levels of Soluble CD6 and Soluble ALCAM Protein in Urine as a Biomarker for Sensitivity to Treatment with EQ001

### Treatment of Spontaneous SLE/Lupis Nephritis (LN) with CD6 Blockade

### Example 5

